Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Arsenic Trioxide Upregulates Cereblon mRNA Expression and Potentiates Sensitivity of SKM-1 and MDS-L Cells to Lenalidomide

Radka Bokorová, Ota Fuchs, PhD, Denisa Myslivcova, PhD, Jaroslav Cermak

Blood (2019) 134 (Supplement_1): 5397.

https://doi.org/10.1182/blood-2019-126443

Published: 2019

Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 1592.

https://doi.org/10.1182/blood-2019-124382

Published: 2019

Journal Articles

Unusual Long Term Remission in Multiple Myeloma Using Conventional Therapy Combined with Danazol

Matthew P Salzberg, MD, Pamela B. Dudkiewicz, DNP, ARNP, Lawrence L. Horstman, BS, Wenche Jy, PhD, Yeon S. Ahn, MD

Blood (2017) 130 (Supplement 1): 5423.

https://doi.org/10.1182/blood.V130.Suppl_1.5423.5423

Published: 2017

Journal Articles

Role of Platelets in Adaptive Changes to Anti-Angiogenesis Therapy

Anil Sood, MD

Blood (2017) 130 (Supplement 1): SCI-27.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-27.SCI-27

Published: 2017

Journal Articles

Efficacy and Safety of Novel Targeted Drug' Apatinib in Relapse or Refractory Non-Hodgkin Lymphoma: An Open Label, Single-Armed, Exploratory Study

Ling Li, MSPH, Sa Xiao, Ken H. Young, MD PhD, Lei Zhang, MD, Xin Li, MD, Xiaorui Fu, MDPhD, Zhaoming Li, MDPhD, Zhenchang Sun, MDPhD, Xudong Zhang, MDPhD, Jiaqin Yan, MDPhD, Feifei Nan, MDPhD, Yu Chang, Mengyuan Shi, graduate student, Mingzhi Zhang

Blood (2017) 130 (Supplement 1): 1548.

https://doi.org/10.1182/blood.V130.Suppl_1.1548.1548

Published: 2017

Journal Articles

Multiple Myeloma Patients with Lenalidomide-Associated Skin Rash Have a Favorable Prognosis

Ayumi Kojima, Yuka Tanaka, Yuta Kimura, Daisuke Tsuchimoto, Rina Etani, Tetsufumi Kanematsu, Kenji Miyazawa, Akiya Mori, Atsuhiko Naruse, Hirokazu Nagai, MD PhD

Blood (2016) 128 (22): 4532.

https://doi.org/10.1182/blood.V128.22.4532.4532

Published: 2016

Journal Articles

Vascular Remodeling Underlies Re-Bleeding in Hemophilic Arthropathy

Annette Von Drygalski, MD PharmD, Vikas Bhat, PhD, Merissa Olmer, MS, Shweta Joshi, PhD, Donald Durden, MD, Thomas J Cramer, PhD, Richard FW Barnes, PhD MPH, Scott T Ball, MD, Tudor H Hughes, MD, Mauricio Silva, MD, James V Luck, MD, Randy Moore, DC,RDMS, Laurent O. Mosnier, PhD

Blood (2015) 126 (23): 1038.

https://doi.org/10.1182/blood.V126.23.1038.1038

Published: 2015

Journal Articles

IMiD® Immunomodulatory Agents Promote Apoptosis in Multiple Myeloma Cells through Induction of TRAIL Expression

Michael D. Amatangelo, PhD, Chad C. Bjorklund, Anita K. Gandhi, PhD, Anke Klippel, Tom Daniel, Rajesh Chopra, MBBS, PhD, Matthew Trotter, Anjan Thakurta

Blood (2015) 126 (23): 5355.

https://doi.org/10.1182/blood.V126.23.5355.5355

Published: 2015

Journal Articles

Gambogic Acid Suppresses Hypoxia-Induced HIF-1α/VEGF Expression Via Inhibiting PI3K/Akt/mTOR Pathway in Multiple Myeloma Cells

Fei Wang, Master, Wei Zhang, Doctor, Liting Guo, Master, Jian Cheng, PhD, Ping Liu, undergraduate, Baoan Chen, PhD Professor

Blood (2014) 124 (21): 5230.

https://doi.org/10.1182/blood.V124.21.5230.5230

Published: 2014

Journal Articles

Wogonin Inhibits Angiogenesis Via a c-Myc/Hif-1α–dependent Pathway in Multiple Myeloma

Rong Fu, PhD, Qinglong Guo, PhD, Yan Chen, Master, Huihui Song, PhD, Baoan Chen, PhD Professor

Blood (2014) 124 (21): 5238.

https://doi.org/10.1182/blood.V124.21.5238.5238

Published: 2014

Journal Articles

A Phase II Trial of TBL12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma

Anjali Varma Desai, MD, Meina Lu, N.P., Sara Marcus, M.P.H., Ankeeta Saran, B.A., Aditya Malankar, B.S., Amitabha Mazumder, MD

Blood (2014) 124 (21): 5733.

https://doi.org/10.1182/blood.V124.21.5733.5733

Published: 2014

Journal Articles

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

Blood (2013) 122 (21): 3211.

https://doi.org/10.1182/blood.V122.21.3211.3211

Published: 2013

Journal Articles

STUDY ON ANTIANGIOGENENIC EFFECT OF ACANTHOPANAX SENTICOSUS IN HL60 CELL LINES

Chen Fangyuan, Sr., M.D, Zhang Minyue, Sr., M.D, Cai Jiayi, Sr., M.D, Shen Lijing, Sr., M.D

Blood (2013) 122 (21): 4857.

https://doi.org/10.1182/blood.V122.21.4857.4857

Published: 2013

Journal Articles

MDS: unraveling the mystery

David A. Rizzieri

Blood (2012) 120 (25): 4906–4908.

https://doi.org/10.1182/blood-2012-09-452755

Published: 2012

Journal Articles

CC-122 Is a Novel Pleiotropic Pathway Modifier with Potent in Vitro Immunomodulatory and Anti-Angiogenic Properties and in Vivo Anti-Tumor Activity in Hematological Cancers.

Anita K Gandhi, PhD, Derek Mendy, BS, Anastasia Parton, BA, Lei Wu, MS, ECFMG, Jolanta Kosek, BA, Ling-Hua Zhang, PhD, Lori Capone, BS, Antonia Lopez-Girona, PhD, Peter H Schafer, PhD, Rajesh Chopra, MD, PhD

Blood (2012) 120 (21): 2963.

https://doi.org/10.1182/blood.V120.21.2963.2963

Published: 2012

Journal Articles

Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

Antonella Caivano, Francesco La Rocca, Alessandra Favole, PhD, Sonia Carturan, PhD, Enrico Bracco, PhD, Oreste Villani, Giuseppe Pietrantuono, Ilaria Laurenzana, Luciana De Luca, MD, Annalisa Morano, Vittorio Simeon, Stefania Trino, Simona Berardi, Antonio Basile, Angelo Vacca, Pellegrino Musto, Daniela Cilloni, MD

Blood (2012) 120 (21): 2926.

https://doi.org/10.1182/blood.V120.21.2926.2926

Published: 2012

Journal Articles

A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients

Vittorio Montefusco, Francesco Spina, MD PhD, Elena Zamagni, MD, Benedetto Bruno, MD, Francesca Gay, Francesca Patriarca, MD, Giorgia Saporiti, MD, Monica Galli, MD, Claudia Crippa, MD, Lucia Farina, MD, PhD, Anna Maria Cafro, Angelo Michele Carella, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 1960.

https://doi.org/10.1182/blood.V120.21.1960.1960

Published: 2012

Journal Articles

Rituximab-CHOP21 Plus Lenalidomide (LR-CHOP21) Is Effective and Feasible in Elderly Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results of Phase II REAL07 Study of the Fondazione Italiana Linfomi (FIL)

Blood (2012) 120 (21): 903.

https://doi.org/10.1182/blood.V120.21.903.903

Published: 2012

Journal Articles

The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients

Sarah Mans, Yara Banz, Beatrice U. Mueller, Thomas Pabst

Blood (2012) 120 (13): 2690–2699.

https://doi.org/10.1182/blood-2012-02-412759

Published: 2012

Includes: Supplemental data

Journal Articles

The Therapeutic Effect of Lenalidomide Is Enhanced After Allogeneic Stem Cell Transplantation: Results of a Case-Control Study

Vittorio Montefusco, MD, Francesco Spina, MD, Elena Zamagni, MD, Giorgia Saporiti, MD, Francesca Patriarca, MD, Monica Galli, MD, Claudia Crippa, MD, Lucia Farina, MD, PhD, Anna Maria Cafro, Paolo Corradini, MD

Blood (2011) 118 (21): 1996.

https://doi.org/10.1182/blood.V118.21.1996.1996

Published: 2011

NARROW

Arsenic Trioxide Upregulates Cereblon mRNA Expression and Potentiates Sensitivity of SKM-1 and MDS-L Cells to Lenalidomide

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Unusual Long Term Remission in Multiple Myeloma Using Conventional Therapy Combined with Danazol

Role of Platelets in Adaptive Changes to Anti-Angiogenesis Therapy

Efficacy and Safety of Novel Targeted Drug' Apatinib in Relapse or Refractory Non-Hodgkin Lymphoma: An Open Label, Single-Armed, Exploratory Study

Multiple Myeloma Patients with Lenalidomide-Associated Skin Rash Have a Favorable Prognosis

Vascular Remodeling Underlies Re-Bleeding in Hemophilic Arthropathy

IMiD® Immunomodulatory Agents Promote Apoptosis in Multiple Myeloma Cells through Induction of TRAIL Expression

Gambogic Acid Suppresses Hypoxia-Induced HIF-1α/VEGF Expression Via Inhibiting PI3K/Akt/mTOR Pathway in Multiple Myeloma Cells

Wogonin Inhibits Angiogenesis Via a c-Myc/Hif-1α–dependent Pathway in Multiple Myeloma

A Phase II Trial of TBL12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

STUDY ON ANTIANGIOGENENIC EFFECT OF ACANTHOPANAX SENTICOSUS IN HL60 CELL LINES

MDS: unraveling the mystery

CC-122 Is a Novel Pleiotropic Pathway Modifier with Potent in Vitro Immunomodulatory and Anti-Angiogenic Properties and in Vivo Anti-Tumor Activity in Hematological Cancers.

Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients

Rituximab-CHOP21 Plus Lenalidomide (LR-CHOP21) Is Effective and Feasible in Elderly Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results of Phase II REAL07 Study of the Fondazione Italiana Linfomi (FIL)

The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients

The Therapeutic Effect of Lenalidomide Is Enhanced After Allogeneic Stem Cell Transplantation: Results of a Case-Control Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only